Psychiatric and cognitive adverse events of eslicarbazepine acetate (ESL) monotherapy on adults with focal seizures: Results from a randomized, double-blind, active-controlled study and a 2-year open-label extension study

被引：0
|
作者：
Dupont, S. [1 ,2 ,3 ]
Fonseca, M. M. [4 ]
Fernandez, G. Castilla [4 ]
Ikedo, F. [4 ]
Pereira, A. [4 ]
Moreira, J. [4 ]
Gama, H. [4 ]
机构：
[1] UMPC, Hop Pitie Salpetriere, AP HP, Epilepsy Unit,CNRS,ICM,UMR 7225,UMRS 975,Inserm, Paris, France
[2] UMPC, Hop Pitie Salpetriere, AP HP, Rehabil Unit,CNRS,ICM,UMR 7225,UMRS 975,Inserm, Paris, France
[3] Univ Paris Sorbonne, Paris, France
[4] BIAL Portela Ca SA, Maia, Portugal
来源：
EPILEPSIA | 2022年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
701
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal-onset seizures: Post-hoc analysis from a phase III, randomized, double-blind study and a 2-year open-label extension ESL study
    Trinka, Eugen
    Rocamora, Rodrigo
    Moreira, Joana
    Pereira, Ana
    Fonseca, Miguel
    Fernandez, Guillermo Castilla
    Ikedo, Fabio
    NEUROLOGY, 2021, 96 (15)
  • [2] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
    van der Heijde, Desiree
    Deodhar, Atul
    Maksymowych, Walter P.
    Sieper, Joachim
    van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Duan, Yuanyuan
    Chu, Alvina D.
    Song, In-Ho
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 26 - 26
  • [3] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 2-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
    van der Heijde, Desiree
    Deodhar, Atul
    Maksymowych, Walter
    Sieper, Joachim
    Van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Duan, Yuanyuan
    Chu, Alvina D.
    Song, In-Ho
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1925 - 1928
  • [4] Long-term efficacy and safety of eslicarbazepine acetate (ESL) monotherapy: results from BIA-2093-311/EXT study -the 2-year open-label extension of the ESL study (BIA-2093-311)
    Trinka, Eugen
    Pereira, Ana
    Moreira, Joana
    Magalhaes, Luis
    Ikedo, Fabio
    Gama, Helena
    NEUROLOGY, 2020, 94 (15)
  • [5] Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)
    Kim, Gyuri
    Lim, Soo
    Kwon, Hyuk-Sang
    Park, Ie B.
    Ahn, Kyu J.
    Park, Cheol-Young
    Kwon, Su K.
    Kim, Hye S.
    Park, Seok W.
    Kim, Sin G.
    Moon, Min K.
    Kim, Eun S.
    Chung, Choon H.
    Park, Kang S.
    Kim, Mikyung
    Chung, Dong J.
    Lee, Chang B.
    Kim, Tae H.
    Lee, Moon-Kyu
    DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1527 - 1536
  • [6] Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
    van der Heijde, Desiree
    Deodhar, Atul
    Maksymowych, Walter P.
    Sieper, Joachim
    Van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew J.
    Combe, Bernard
    Sui, Yunxia
    Duan, Yuanyuan
    Wung, Peter K.
    Song, In-Ho
    RMD OPEN, 2022, 8 (02):
  • [7] Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
    Boonen, Steven
    Lorenc, Roman S.
    Wenderoth, Dietrich
    Stoner, Karen J.
    Eusebio, Rachelle
    Orwoll, Eric S.
    BONE, 2012, 51 (03) : 383 - 388
  • [8] CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS: RESULTS FROM AN ONGOING OPEN-LABEL EXTENSION OF A DOUBLE-BLIND RANDOMIZED DOSE RANGING STUDY
    Rosenfeld, W.
    Wiegand, F.
    Schmitt, J.
    Novak, G.
    EPILEPSIA, 2009, 50 : 52 - 52
  • [9] Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study
    Trinka, Eugen
    Rocamora, Rodrigo
    Chaves, Joao
    Moreira, Joana
    Ikedo, Fabio
    Soares-da-Silva, Patricio
    EPILEPSIA, 2020, 61 (10) : 2129 - 2141
  • [10] Efficacy and Safety of Upadacitinib in Patients With Active Ankylosing Spondylitis: 1-Year Results From a Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension
    Maksymowych, Walter
    van der Heijde, Desiree
    Sieper, Joachim
    van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina
    Song, In-Ho
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1122 - 1122
12345